Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate

 The Board of Directors of the Company at its meeting held on 8th February, 2021, have:- 1. Appointed Mr. Jasmine Shah (DIN: 08621290) as an Additional Director & Chairman 2. Appointed Prof. (Dr.) Mahesh Verma (DIN: 0008997324) as an Additional Director. 3. Appointed Mr. Salil Singhal (DIN: 00006629) as Independent Director of the Company, for a period of 5 consecutive years effective from 8th February, 2021 to 7th February, 2026, 4. Re-appointed Mr. Vinayak Chatterjee (DIN : 00008933) as Independent Director of the Company, for a period of 5 consecutive years effective from 1st April, 2021 to 31st March, 2026, 5. Noted the withdrawal of nomination of Ms. Vineeta Rai (DIN: 07013113) as a Nominee Director of Govt. of NCT of Delhi on the Board of Directors of the Company; and 6. Appointed Ms. Vineeta Rai (DIN: 07013113) as Independent Director of the Company, for a period of 5 consecutive years effective from 8th February, 2021 to 7th February, 2026.
08-02-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2020

 The Board of Directors of the Company, at their meeting held on 8th February, 2021, have approved the Unaudited Financial Results for the quarter and nine months ended 31st December, 2020. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and nine months ended 31st December, 2020, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 12.15 p.m. and ended at 02:40 p.m. This is for your information and record.
08-02-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Unaudited Financial Results For The Period Ended 31St December, 2020

 INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Monday, 8th February, 2021, inter-alia to consider and approve, the unaudited financial results for the quarter and nine months ended 31st December, 2020
29-01-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholding for the Period Ended December 31, 2020

 Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
19-01-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the provisions of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that we have received request from shareholders for issue of duplicate share certificates in lieu of share certificates reported lost, as per details enclosed. This is for your information and record.
15-01-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Statement Of Investor Complaints For The Quarter Ended December 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 020200 Name of the Signatory :- PRIYA RANJANDesignation :- Company Secretary and Compliance Officer
12-01-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

 Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st January, 2021 till 48 hours after the declaration of financial results for the quarter ending 31st December, 2020. This is for your information and record.
23-12-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2020

 Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 30th September, 2020. This is for your information and record
18-11-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2020

 The Board of Directors of the Company, at their meeting held on 10th November, 2020, have, inter alia, approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2020. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2020, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 12 noon and ended at 03.15 p.m. This is for your information and record.
10-11-2020
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2020

 The Board of Directors of the Company, at their meeting held on 10th November, 2020, have, inter alia, approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2020. We are enclosing herewith a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2020, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 12 noon and ended at 03.15 p.m. This is for your information and record.
10-11-2020
Next Page
Close

Let's Open Free Demat Account